[{"StockholdersEquityConverted_0_Q1_USD":4021000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":171000000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":163000000.0,"EarningsPerShareDiluted_1_Q1_USD":0.49,"CommonStockSharesOutstanding_0_Q1_shares":171032640.0,"StockholdersEquity_0_Q1_USD":4021000000.0,"Assets_0_Q1_USD":10183000000.0,"CommonStockSharesConverted_0_Q1_shares":171032640.0,"NetIncomeLossConverted_1_Q1_USD":84000000.0,"RevenuesConverted_1_Q1_USD":1025000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":172000000.0,"EarningsPerShareBasic_1_Q1_USD":0.49,"Ticker":"CTLT","CIK":"1596783","name":"CATALENT, INC.","OfficialName":"Catalent Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2022.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"17076283108.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20211102"}]